Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The RA patients had a significantly reduced vitamin 25(OH)D level compared to the healthy controls.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The RA patients were categorized based on rheumatoid factor (RF) seropositivity or seronegativity and the RA severity.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Pro‐inflammatory cytokine IL‐21 correlates with the reactive oxygen species and 25‐hydroxy vitamin D in rheumatoid arthritis patients

Study design awaiting verification · Immunity, Inflammation and Disease · 2024

Original publication title

Pro‐inflammatory cytokine IL‐21 correlates with the reactive oxygen species and 25‐hydroxy vitamin D in rheumatoid arthritis patients

Ma Shufang; Han Xiaojiao; Kang Yinhong

© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This is the first investigation to confirm the relationship between IL‐21 with vitamin 25(OH)D and the ROS among the RA patients. The findings indicate that vitamin 25(OH)D is reduced in the RA patients' serum. ROS and IL‐21 are also associated with increased RA severity.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Rheumatoid arthritis (RA) is a chronic autoimmune disorder and its characteristics include the immune system's invasion of the healthy lining of the joints and the articular structures degeneration. The IL‐21 pro‐inflammatory cytokine, and the reactive oxygen species (ROS) might have a role in the RA etiopathogenesis. The present study assessed the correlation of IL‐21 with vitamin 25(OH)D and the ROS.

Source: Background

Abstract: What methods does the paper describe?

The study included 120 RA patients and 60 healthy group. The RA patients were categorized based on rheumatoid factor (RF) seropositivity or seronegativity and the RA severity. Chemiluminescent immunoassay and 10% hematocrit were used to check levels of vitamin 25(OH)D and ROS, respectively. ELISA was used for the detection of IL‐21 in the plasma.

Source: Methods

Abstract: Results

The RA patients had a significantly reduced vitamin 25(OH)D level compared to the healthy controls. The IL‐21 and ROS were however significantly increased in the RA patients compared to the controls. Further, the seropositive RF and the high RA severity patients had significant IL‐21 and ROS increase in comparison with the seronegative RF and the low severity RA patients. Finally, IL‐21 negatively correlated with vitamin 25(OH)D, but positively correlated with the ROS.

Source: Results

Abstract: Conclusion

This is the first investigation to confirm the relationship between IL‐21 with vitamin 25(OH)D and the ROS among the RA patients. The findings indicate that vitamin 25(OH)D is reduced in the RA patients' serum. ROS and IL‐21 are also associated with increased RA severity.

Source: Conclusion
Authors’ abstract

Abstract

Background

Rheumatoid arthritis (RA) is a chronic autoimmune disorder and its characteristics include the immune system's invasion of the healthy lining of the joints and the articular structures degeneration. The IL‐21 pro‐inflammatory cytokine, and the reactive oxygen species (ROS) might have a role in the RA etiopathogenesis. The present study assessed the correlation of IL‐21 with vitamin 25(OH)D and the ROS.

Methods

The study included 120 RA patients and 60 healthy group. The RA patients were categorized based on rheumatoid factor (RF) seropositivity or seronegativity and the RA severity. Chemiluminescent immunoassay and 10% hematocrit were used to check levels of vitamin 25(OH)D and ROS, respectively. ELISA was used for the detection of IL‐21 in the plasma.

Results

The RA patients had a significantly reduced vitamin 25(OH)D level compared to the healthy controls. The IL‐21 and ROS were however significantly increased in the RA patients compared to the controls. Further, the seropositive RF and the high RA severity patients had significant IL‐21 and ROS increase in comparison with the seronegative RF and the low severity RA patients. Finally, IL‐21 negatively correlated with vitamin 25(OH)D, but positively correlated with the ROS.

Conclusion

This is the first investigation to confirm the relationship between IL‐21 with vitamin 25(OH)D and the ROS among the RA patients. The findings indicate that vitamin 25(OH)D is reduced in the RA patients' serum. ROS and IL‐21 are also associated with increased RA severity.

Publication and source details

Original title: Pro‐inflammatory cytokine IL‐21 correlates with the reactive oxygen species and 25‐hydroxy vitamin D in rheumatoid arthritis patients

Ma Shufang; Han Xiaojiao; Kang Yinhong

Immunity, Inflammation and Disease · 2024

* Correspondence Ma Shufang, Rheumatology and Immunology Department, Fourth Central Hospital of Baoding City, Tang County, Hebei Province, China.
Email: drmasf@hotmail.com
© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:12:25.060427+00:00

DOI: 10.1002/iid3.1308 · PMC11273535